Pacira BioSciences, Inc. PCRX Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s work in process?
- Pacira BioSciences, Inc. (PCRX) reported work in process of $39.88M in Q1 2026.
- How has Pacira BioSciences, Inc.'s work in process changed year-over-year?
- Pacira BioSciences, Inc.'s work in process increased by 23.5% year-over-year, from $32.28M to $39.88M.
- What is the long-term trend for Pacira BioSciences, Inc.'s work in process?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s work in process has grown at a 11.6% compound annual growth rate (CAGR), from $16.27M to $28.2M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.